The good news is “yes, you can stay on-budget!“. The “Plan A” is an analytical approach to cost-effective Risk Based Budgeting (RBB). Authors Igor Stefanov, CEO Synergy Research Group, and Artem Andrianov, CEO Cyntegrity, explain how understanding, quantifying and mitigating risks that may impact clinical outcomes can lead to an overall cost reduction of 2%. Read how RBB can help you keeping your clinical trial on-budget.

Visit Applied Clinical Trials – ACT: RBB: 5-steps to stay on-budget